Long-term IL-2 treatment decreased the activity and proliferation of intrarenal conventional CD4+ T cells, which was accompanied by a clinical and histological improvement of lupus nephritis, according to research, while short-term IL-2 treatment increased the intrarenal Treg population in mice with active lupus nephritis [77]. This evidence concerns the gene IL2 and lupus nephritis.